JDM MEDICINES OPTIMISATION LTD

Company Registration Number:
12989347 (England and Wales)

Unaudited micro entity accounts for the year ended 30 November 2023

Period of accounts

Start date: 01 December 2022

End date: 30 November 2023

JDM MEDICINES OPTIMISATION LTD

Contents of the Financial Statements

for the Period Ended 30 November 2023

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

JDM MEDICINES OPTIMISATION LTD

Company Information

for the Period Ended 30 November 2023




Registered office: 15
Charnwood Grove
West Bridgford
Nottingham
GBR
NG2 7NT
Company Registration Number: 12989347 (England and Wales)

JDM MEDICINES OPTIMISATION LTD

Profit and Loss Account

for the Period Ended 30 November 2023


2023
£

2022
£
Turnover 10,850 6,640
Other charges ( 5,098 ) ( 2,271 )
Tax on Profit ( 1,093 ) ( 830 )
Profit or (Loss) for Period 4,659 3,539

JDM MEDICINES OPTIMISATION LTD

Balance sheet

As at 30 November 2023


2023
£

2022
£
Current assets: 5,166 4,379
Creditors: amounts falling due within one year: ( 793 ) ( 482 )
Net current assets (liabilities): 4,373 3,897
Total assets less current liabilities: 4,373 3,897
Provision for liabilities: ( 1,093 ) ( 830 )
Total net assets (liabilities): 3,280 3,067
Capital and reserves: 3,280 3,067

JDM MEDICINES OPTIMISATION LTD

Balance sheet continued

For the year ending 30 November 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 August 2024
And Signed On Behalf Of The Board By:

Name: JAMES DAVID MUSK
Status: Director

The notes form part of these financial statements

JDM MEDICINES OPTIMISATION LTD

Footnotes to the Financial Statements

for the Period Ended 30 November 2023

  • 1. Employee Information

    Average number of employees: 1

JDM MEDICINES OPTIMISATION LTD

Footnotes to the Financial Statements

for the Period Ended 30 November 2023

  • 2. Off balance sheet disclosure

    No